Sort by
Items per page

Send to

Choose Destination

Best matches for atherosclerosis probiotic:

Search results

Items: 1 to 20 of 99


Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications.

Pignanelli M, Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Urquhart BL, Ruetz KN, Velenosi TJ, Spence JD.

J Ren Nutr. 2018 Aug 9. pii: S1051-2276(18)30128-6. doi: 10.1053/j.jrn.2018.05.007. [Epub ahead of print]


Mechanisms of Action of Kefir in Chronic Cardiovascular and Metabolic Diseases.

Pimenta FS, Luaces-Regueira M, Ton AM, Campagnaro BP, Campos-Toimil M, Pereira TM, Vasquez EC.

Cell Physiol Biochem. 2018 Aug 9;48(5):1901-1914. doi: 10.1159/000492511. [Epub ahead of print]


Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.

Qiu L, Tao X, Xiong H, Yu J, Wei H.

Food Funct. 2018 Aug 15;9(8):4299-4309. doi: 10.1039/c8fo00349a.


The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade.

Robles-Vera I, Toral M, de la Visitación N, Sánchez M, Romero M, Olivares M, Jiménez R, Duarte J.

Mol Nutr Food Res. 2018 Jul 20:e1800298. doi: 10.1002/mnfr.201800298. [Epub ahead of print]


Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.

Bu J, Wang Z.

Gastroenterol Res Pract. 2018 Jun 3;2018:6458094. doi: 10.1155/2018/6458094. eCollection 2018. Review.


Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function.

Pignanelli M, Just C, Bogiatzi C, Dinculescu V, Gloor GB, Allen-Vercoe E, Reid G, Urquhart BL, Ruetz KN, Velenosi TJ, Spence JD.

Nutrients. 2018 Jun 16;10(6). pii: E779. doi: 10.3390/nu10060779.


Lactobacillus plantarum reverse diabetes-induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase pathways.

Liu WC, Yang MC, Wu YY, Chen PH, Hsu CM, Chen LW.

PLoS One. 2018 May 31;13(5):e0196511. doi: 10.1371/journal.pone.0196511. eCollection 2018.


Metabolic products of the intestinal microbiome and extremes of atherosclerosis.

Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Wong RG, Urquhart BL, Dinculescu V, Ruetz KN, Velenosi TJ, Pignanelli M, Spence JD.

Atherosclerosis. 2018 Jun;273:91-97. doi: 10.1016/j.atherosclerosis.2018.04.015. Epub 2018 Apr 17.


Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.

Khor BH, Narayanan SS, Sahathevan S, Gafor AHA, Daud ZAM, Khosla P, Sabatino A, Fiaccadori E, Chinna K, Karupaiah T.

Nutrients. 2018 Mar 23;10(4). pii: E397. doi: 10.3390/nu10040397. Review.


The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.

Kasselman LJ, Vernice NA, DeLeon J, Reiss AB.

Atherosclerosis. 2018 Apr;271:203-213. doi: 10.1016/j.atherosclerosis.2018.02.036. Epub 2018 Mar 2. Review.


Myocardial infarction and gut microbiota: An incidental connection.

Zununi Vahed S, Barzegari A, Zuluaga M, Letourneur D, Pavon-Djavid G.

Pharmacol Res. 2018 Mar;129:308-317. doi: 10.1016/j.phrs.2017.11.008. Epub 2017 Nov 10. Review.


Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Nutr Rev. 2017 Sep 1;75(9):731-767. doi: 10.1093/nutrit/nux047. Review.


The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.

Ding YH, Qian LY, Pang J, Lin JY, Xu Q, Wang LH, Huang DS, Zou H.

Oncotarget. 2017 Jun 2;8(35):59915-59928. doi: 10.18632/oncotarget.18346. eCollection 2017 Aug 29. Review.


Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.

Hu WS, Rajendran P, Tzang BS, Yeh YL, Shen CY, Chen RJ, Ho TJ, Vijaya Padma V, Chen YH, Huang CY.

PLoS One. 2017 Sep 21;12(9):e0185098. doi: 10.1371/journal.pone.0185098. eCollection 2017.


Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases.

Lau K, Srivatsav V, Rizwan A, Nashed A, Liu R, Shen R, Akhtar M.

Nutrients. 2017 Aug 10;9(8). pii: E859. doi: 10.3390/nu9080859. Review.


Enterobacter aerogenes ZDY01 Attenuates Choline-Induced Trimethylamine N-Oxide Levels by Remodeling Gut Microbiota in Mice.

Qiu L, Yang D, Tao X, Yu J, Xiong H, Wei H.

J Microbiol Biotechnol. 2017 Aug 28;27(8):1491-1499. doi: 10.4014/jmb.1703.03039.


[Microbiota and metabolic syndrome].

Altuntaş Y, Batman A.

Turk Kardiyol Dern Ars. 2017 Apr;45(3):286-296. doi: 10.5543/tkda.2016.72461. Turkish.


Streptococcus thermophilus fermented milk reduces serum MDA-LDL and blood pressure in healthy and mildly hypercholesterolaemic adults.

Ito M, Kusuhara S, Yokoi W, Sato T, Ishiki H, Miida S, Matsui A, Nakamori K, Nonaka C, Miyazaki K.

Benef Microbes. 2017 Apr 26;8(2):171-178. doi: 10.3920/BM2016.0102. Epub 2017 Mar 16.


Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-/- mice.

Ryan PM, London LE, Bjorndahl TC, Mandal R, Murphy K, Fitzgerald GF, Shanahan F, Ross RP, Wishart DS, Caplice NM, Stanton C.

Microbiome. 2017 Mar 13;5(1):30. doi: 10.1186/s40168-017-0246-x.


Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.

Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E.

Curr Diab Rep. 2017 Mar;17(3):16. doi: 10.1007/s11892-017-0841-z. Review.


Supplemental Content

Loading ...
Support Center